(Q36028642)

11 August 2017

1 reference

title

Small molecule epidermal growth factor receptor tyrosine kinase inhibitors: an overview (English)

1 reference

11 August 2017

Normanno N

1

1 reference

11 August 2017

Maiello MR

series ordinal

2

1 reference

11 August 2017

Mancino M

series ordinal

3

1 reference

11 August 2017

De Luca A

series ordinal

4

1 reference

11 August 2017

publication date

1 November 2004

1 reference

11 August 2017

published in

Journal of Chemotherapy

1 reference

11 August 2017

volume

16 Suppl 4

1 reference

11 August 2017

page(s)

36-40

1 reference

Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.36

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.36

Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.36

Phase II trial of gefitinib in recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.36

Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.36

Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs): simple drugs with a complex mechanism of action?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.36

Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.36

Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.36

10.1179/JOC.2004.16.SUPPLEMENT-1.36

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference